Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $127 Billion
- Q4 2024
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 2,355,683 shares of PODD stock, worth $635 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
2,355,683
Previous 2,275,701
3.51%
Holding current value
$635 Million
Previous $530 Million
16.11%
% of portfolio
0.49%
Previous 0.4%
Shares
5 transactions
Others Institutions Holding PODD
# of Institutions
754Shares Held
63.4MCall Options Held
467KPut Options Held
639K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.29 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$2.01 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.63 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$802 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.78MShares$480 Million0.04% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...